Despite an overall increase in public health awareness, the prevalence of obesity remains epidemically high. Worldwide, over half a billion people are currently classified as obese (body mass index [BMI] ≥ 30 kg/m 2 ), and it is estimated that over 40% of the U.S population will be obese by the year 2030 [1]. These statistics are of serious concern because of the recognized relationship between obesity and chronic disease, specifically cardiovascular disease (CVD) being the number one cause of death in the United States [2].Even in the absence of other cardiac related comorbidities, excess adipose tissue often induces dyslipidaemia, hypertension and glucose intolerance, all indicative of metabolic syndrome [3]. While each of these components is known to increase CVD risk independently, the combination of these markers and the presence of metabolic syndrome itself is associated with a significant long-term risk of CVD [4].Strong evidence suggests that healthy lifestyle habits can influence CVD risk factors [5]. For example, when observing more than 80,000 nurses, over 90% of diabetes mellitus cases, 57% of hypertension cases, and 40% of hypercholesterolemia cases were attributed to poor lifestyle factors [6]. Research has also showed that a combination of at least three low risk lifestyle factors and a BMI between 18.5-22.4 is associated with the lowest risk of CVD (0.37, 0.29 to 0.46) mortality, when compared with those with a BMI between 22.5-24.9 and none of the four low-risk lifestyle factors [7]. This emphasizes the importance of maintaining a healthy weight and the prevention of clinical risk factor development, recognizing the value of primordial prevention.Primordial prevention is defined as the prevention of the risk factors themselves, before the individual is negatively affected by the symptoms [8]. This is often thought of as radical, especially in young patients who don't currently exhibit concerning biomarkers. Primordial prevention differs from primary prevention in that the emphasis is on early dietary and lifestyle modifications to prevent the risk factors in the first place. If these risk factors are proven to lead to the onset of disease, why would health providers not want to prevent them from occurring in the first place? This is especially true when considering the alarming long-term risk that the obese population faces for developing CVD despite a perceived low short-term risk [4].Currently, there are numerous risk prediction tools that include in their assessment clinical risk factors such as blood pressure, and blood lipids to estimate an individual's short term (i.e., 10-years) risk of CVD. For individuals with a high risk based on these factors, it is common practice to attempt to decrease risk pharmacologically [9]. However, individuals with a low short term risk but elevated long term risk may benefit from alternative methods of risk factor management. In addition, the fact that drug therapy is usually prescribed when short term risk is high (>7.5% over 10 years) has led to hypertens...